EU experts add new warnings to Glaxo’s Avandia
European regulators recommended that patients with heart disease or leg pains, a possible sign of heart problems should not take GlaxoSmithKline's diabetes drug Avandia.
The European Medicines Agency also said in its decision to update Avandia's label that the drug must not be used by people having a heart attack or ...
